nodes	percent_of_prediction	percent_of_DWPC	metapath
Drostanolone—SHBG—Nongenotropic Androgen signaling—PLCB1—Alzheimer's disease	0.0567	0.0589	CbGpPWpGaD
Drostanolone—CYP19A1—Endogenous sterols—CYP46A1—Alzheimer's disease	0.0484	0.0502	CbGpPWpGaD
Drostanolone—CYP19A1—Tryptophan metabolism—DHCR24—Alzheimer's disease	0.0416	0.0432	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—RCAN1—Alzheimer's disease	0.036	0.0374	CbGpPWpGaD
Drostanolone—SHBG—Nongenotropic Androgen signaling—CREB1—Alzheimer's disease	0.0311	0.0322	CbGpPWpGaD
Drostanolone—CYP19A1—Tryptophan metabolism—HSD17B10—Alzheimer's disease	0.0289	0.0299	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—GRN—Alzheimer's disease	0.0247	0.0256	CbGpPWpGaD
Drostanolone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.0225	0.0233	CbGpPWpGaD
Drostanolone—CYP19A1—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.0222	0.023	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—GRN—Alzheimer's disease	0.0212	0.022	CbGpPWpGaD
Drostanolone—Trilostane—ESR1—Alzheimer's disease	0.0208	0.575	CrCbGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.0182	0.0189	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—PLCB1—Alzheimer's disease	0.0176	0.0182	CbGpPWpGaD
Drostanolone—CYP19A1—Tryptophan metabolism—MAOB—Alzheimer's disease	0.0166	0.0172	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—YWHAQ—Alzheimer's disease	0.0147	0.0153	CbGpPWpGaD
Drostanolone—CYP19A1—FSH signaling pathway—BDNF—Alzheimer's disease	0.0137	0.0142	CbGpPWpGaD
Drostanolone—SHBG—Nongenotropic Androgen signaling—AKT1—Alzheimer's disease	0.0125	0.0129	CbGpPWpGaD
Drostanolone—AR—FOXA1 transcription factor network—SOD1—Alzheimer's disease	0.0115	0.0119	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—PTK2B—Alzheimer's disease	0.0114	0.0119	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.0109	0.0113	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.0105	0.0109	CbGpPWpGaD
Drostanolone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.00996	0.0103	CbGpPWpGaD
Drostanolone—CYP19A1—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.00983	0.0102	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—CYP46A1—Alzheimer's disease	0.00967	0.01	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—CREB1—Alzheimer's disease	0.00962	0.00998	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.00954	0.0099	CbGpPWpGaD
Drostanolone—CYP19A1—FSH signaling pathway—CREB1—Alzheimer's disease	0.00924	0.00959	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptors—ESR1—Alzheimer's disease	0.00908	0.00942	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.0089	0.00923	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.0089	0.00923	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.00862	0.00894	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptors—PPARG—Alzheimer's disease	0.00829	0.0086	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.00823	0.00854	CbGpPWpGaD
Drostanolone—AR—FOXA1 transcription factor network—ESR1—Alzheimer's disease	0.00808	0.00838	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.00807	0.00838	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.00756	0.00785	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—NOTCH1—Alzheimer's disease	0.00741	0.00769	CbGpPWpGaD
Drostanolone—AR—FOXA1 transcription factor network—INS—Alzheimer's disease	0.00723	0.0075	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptor transcription pathway—ESR1—Alzheimer's disease	0.00718	0.00745	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.00711	0.00738	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.00698	0.00724	CbGpPWpGaD
Drostanolone—Estradiol—ESR1—Alzheimer's disease	0.00655	0.181	CrCbGaD
Drostanolone—AR—Nuclear Receptor transcription pathway—PPARG—Alzheimer's disease	0.00655	0.00679	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.00638	0.00662	CbGpPWpGaD
Drostanolone—AR—Regulation of Androgen receptor activity—GSK3B—Alzheimer's disease	0.00631	0.00655	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—MEF2C—Alzheimer's disease	0.00614	0.00637	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—EIF2AK2—Alzheimer's disease	0.00605	0.00628	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.0058	0.00602	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—MAOB—Alzheimer's disease	0.00577	0.00599	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.00573	0.00595	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—MAPT—Alzheimer's disease	0.0056	0.00581	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.00557	0.00578	CbGpPWpGaD
Drostanolone—Progesterone—ESR1—Alzheimer's disease	0.00556	0.153	CrCbGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CST3—Alzheimer's disease	0.00543	0.00563	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.00539	0.00559	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—GSK3A—Alzheimer's disease	0.00533	0.00553	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.00524	0.00544	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.00524	0.00544	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—IAPP—Alzheimer's disease	0.00508	0.00527	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—ACHE—Alzheimer's disease	0.00499	0.00518	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—Alzheimer's disease	0.00496	0.00514	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—CAV1—Alzheimer's disease	0.00477	0.00495	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—GSK3A—Alzheimer's disease	0.00459	0.00476	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—CREB1—Alzheimer's disease	0.00446	0.00463	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	0.00442	0.00459	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—PTGS1—Alzheimer's disease	0.00437	0.00454	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	0.00435	0.00451	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—CYP2D6—Alzheimer's disease	0.00429	0.00445	CbGpPWpGaD
Drostanolone—AR—Regulation of Androgen receptor activity—MAPK8—Alzheimer's disease	0.00426	0.00442	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.00423	0.00439	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—GSK3B—Alzheimer's disease	0.00417	0.00433	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—CREB1—Alzheimer's disease	0.00414	0.00429	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.00403	0.00418	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.00402	0.00418	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.00391	0.00406	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—AKT1—Alzheimer's disease	0.00386	0.004	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	0.00376	0.0039	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—BAX—Alzheimer's disease	0.00374	0.00388	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.00371	0.00385	CbGpPWpGaD
Drostanolone—CYP19A1—FSH signaling pathway—AKT1—Alzheimer's disease	0.00371	0.00384	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.00363	0.00377	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.00347	0.0036	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	0.00333	0.00345	CbGpPWpGaD
Drostanolone—Progesterone—CYP2D6—Alzheimer's disease	0.00331	0.0913	CrCbGaD
Drostanolone—AR—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.00331	0.00343	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—BAX—Alzheimer's disease	0.00322	0.00334	CbGpPWpGaD
Drostanolone—AR—Gene Expression—PHF1—Alzheimer's disease	0.00315	0.00327	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	0.0031	0.00321	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—ESR1—Alzheimer's disease	0.00301	0.00313	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CREB1—Alzheimer's disease	0.00271	0.00281	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	0.00264	0.00274	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—ESR1—Alzheimer's disease	0.00259	0.00269	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	0.0025	0.00259	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—DHCR24—Alzheimer's disease	0.00248	0.00257	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CREB1—Alzheimer's disease	0.00233	0.00242	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.00231	0.0024	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—BCL2—Alzheimer's disease	0.00228	0.00236	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	0.00225	0.00233	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—AKT1—Alzheimer's disease	0.00224	0.00233	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	0.00216	0.00224	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CA4—Alzheimer's disease	0.00211	0.00219	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	0.00206	0.00214	CbGpPWpGaD
Drostanolone—AR—Gene Expression—TFAM—Alzheimer's disease	0.00203	0.00211	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CASP3—Alzheimer's disease	0.00201	0.00208	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GAPDHS—Alzheimer's disease	0.00198	0.00206	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	0.00196	0.00203	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—BCL2—Alzheimer's disease	0.00196	0.00203	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	0.00195	0.00203	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	0.00189	0.00196	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ATP5A1—Alzheimer's disease	0.00188	0.00195	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PLD3—Alzheimer's disease	0.00179	0.00186	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	0.00179	0.00186	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	0.00179	0.00186	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—Alzheimer's disease	0.00179	0.00186	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	0.00177	0.00184	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CASP3—Alzheimer's disease	0.00173	0.00179	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—HSD17B10—Alzheimer's disease	0.00172	0.00178	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—VEGFA—Alzheimer's disease	0.0017	0.00177	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	0.00168	0.00174	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	0.00166	0.00173	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	0.00166	0.00172	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—AKT1—Alzheimer's disease	0.00166	0.00172	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CYP46A1—Alzheimer's disease	0.00165	0.00172	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ND1—Alzheimer's disease	0.0016	0.00166	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	0.00156	0.00162	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	0.00153	0.00159	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—Alzheimer's disease	0.00147	0.00152	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	0.00143	0.00148	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	0.00142	0.00148	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	0.00141	0.00146	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	0.00129	0.00134	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	0.00129	0.00133	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—ESR1—Alzheimer's disease	0.00124	0.00129	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	0.00123	0.00128	CbGpPWpGaD
Drostanolone—AR—Gene Expression—EIF2S1—Alzheimer's disease	0.00122	0.00127	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	0.00121	0.00125	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	0.0012	0.00124	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	0.00115	0.00119	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—PPARG—Alzheimer's disease	0.00113	0.00117	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	0.00112	0.00116	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	0.00111	0.00115	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	0.00109	0.00113	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	0.00107	0.00111	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—TPI1—Alzheimer's disease	0.00103	0.00107	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CHAT—Alzheimer's disease	0.00103	0.00107	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—MAOB—Alzheimer's disease	0.000987	0.00102	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GAPDH—Alzheimer's disease	0.00095	0.000986	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	0.000939	0.000975	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	0.000935	0.00097	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	0.000931	0.000966	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—A2M—Alzheimer's disease	0.000918	0.000952	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	0.0009	0.000934	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	0.000818	0.000849	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ACHE—Alzheimer's disease	0.000798	0.000828	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—INPP5D—Alzheimer's disease	0.000789	0.000819	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ENO1—Alzheimer's disease	0.000748	0.000776	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PTGS1—Alzheimer's disease	0.000748	0.000776	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CYP2D6—Alzheimer's disease	0.000733	0.000761	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—BCHE—Alzheimer's disease	0.000695	0.000721	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PLCB1—Alzheimer's disease	0.000656	0.000681	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	0.000644	0.000668	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ABCA1—Alzheimer's disease	0.000636	0.00066	CbGpPWpGaD
Drostanolone—AR—Gene Expression—ESR1—Alzheimer's disease	0.000597	0.000619	CbGpPWpGaD
Drostanolone—AR—Gene Expression—NOTCH1—Alzheimer's disease	0.000577	0.000599	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PPARGC1A—Alzheimer's disease	0.000548	0.000569	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—HMOX1—Alzheimer's disease	0.000546	0.000566	CbGpPWpGaD
Drostanolone—AR—Gene Expression—PPARG—Alzheimer's disease	0.000545	0.000565	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—LPL—Alzheimer's disease	0.000499	0.000518	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—MTHFR—Alzheimer's disease	0.000449	0.000466	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CALM1—Alzheimer's disease	0.00042	0.000436	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—APOE—Alzheimer's disease	0.000418	0.000434	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CAV1—Alzheimer's disease	0.000414	0.00043	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PPARG—Alzheimer's disease	0.000364	0.000378	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—INS—Alzheimer's disease	0.000357	0.000371	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—NOS3—Alzheimer's disease	0.000313	0.000325	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PTGS2—Alzheimer's disease	0.000287	0.000297	CbGpPWpGaD
Drostanolone—AR—Gene Expression—AKT1—Alzheimer's disease	0.000215	0.000223	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—AKT1—Alzheimer's disease	0.000144	0.000149	CbGpPWpGaD
